<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJGen</journal-id><journal-title-group><journal-title>Open Journal of Genetics</journal-title></journal-title-group><issn pub-type="epub">2162-4453</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojgen.2014.43019</article-id><article-id pub-id-type="publisher-id">OJGen-46550</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>MEDICINE &amp; HEALTHCARE</subject><subject>BIOMEDICAL &amp; LIFE SCIENCES</subject></subj-group></article-categories><title-group><article-title>ADRBD1 (GRK2), TBXA2R and VEGFA rSNPs in KLF4 and SP1 TFBS Exhibit Linkage Disequilibrium</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Norman</surname><given-names>E. Buroker</given-names></name><xref ref-type="aff" rid="aff1"><sub>1</sub></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Pediatrics, University of Washington, Seattle, USA</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>nburoker@u.washington.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>04</day><month>06</month><year>2014</year></pub-date><volume>04</volume><issue>03</issue><fpage>183</fpage><lpage>189</lpage><history><date date-type="received"><day>8</day>	<month>March</month>	<year>2014</year></date><date date-type="rev-recd"><day>7</day>	<month>April</month>	<year>2014</year>	</date><date date-type="accepted"><day>6</day>	<month>May</month>	<year>2014</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
	The adrenergic
receptor kinase 1 (ADRBK1), thromboxane
A2 receptor (TBXA2R) and vascular endothelial growth
factor (VEGFA) regulatory (r) single
nucleotide polymorphisms (SNPs) found in the potential stimulating protein-1
(SP1) and Kruppel-like factor-4 (KLF4) transcriptional factor binding sites (TFBS)
within these genes are in linkage disequilibrium (LD). The LD may result from
rSNP alleles that create TFBS for the KLF4 and SP1 transcriptional factors (TF)
since the alternate rSNP alleles do not create these TFBS. Consequently,
haplotypes carrying the rSNP alleles that create KLF4 and SP1 TFBS are
essential for ADRBK1, TBXA2R and VEGFA gene
regulation by these TFs. 
</p></abstract><kwd-group><kwd>&lt;i&gt;ADRBD1&lt;/i&gt; (GRK2)</kwd><kwd> &lt;i&gt;TBXA2R&lt;/i&gt;</kwd><kwd> &lt;i&gt;VEGFA&lt;/i&gt;</kwd><kwd> KLF4</kwd><kwd> SP1</kwd><kwd> TFBS</kwd><kwd> rSNP</kwd><kwd> LD</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>The transcription factor (TF) stimulating protein-1 (SP1) participates in the transcription regulation of Kruppel- like factor-4 (KLF4), a zinc finger-containing TF and together they are part of a (SP1/KLF) family of TFs which play a role in diverse cellular processes, including vascular smooth muscle cell (VSMC) proliferation, cell differentiation, apoptosis and, oncogenic processes [<xref ref-type="bibr" rid="scirp.46550-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.46550-ref2">2</xref>] , induction of pluripotent stem cells [<xref ref-type="bibr" rid="scirp.46550-ref3">3</xref>] and control of gene transcription [<xref ref-type="bibr" rid="scirp.46550-ref4">4</xref>] -[<xref ref-type="bibr" rid="scirp.46550-ref7">7</xref>] . There have been at least 20 KLFs identified in mammals with each individually participating in one of the above biological functions [<xref ref-type="bibr" rid="scirp.46550-ref6">6</xref>] . KLF4 has been shown to play a key role in pathological vascular processes and is considered as a molecular switch in regulating VSMC function [<xref ref-type="bibr" rid="scirp.46550-ref6">6</xref>] . KLF4 and SP1 physically interact, occupy the angiotensin II type 1 receptor (AT1R) promoter and induce AT1R transcription in</p><p>VSMCs in a co-operative manner under basal conditions [<xref ref-type="bibr" rid="scirp.46550-ref8">8</xref>] . KLF4 and SP1 also have transcriptional factor binding sites (TFBS) in the regulatory regions of the adrenergic receptor kinase 1 (ADRBK1), thromboxane A2 receptor (TBXA2R) and vascular endothelial growth factor (VEGFA) genes. The SP1 TF has been shown to bind its transcriptional factor binding site (TFBS) and regulate the ADRBK1 [<xref ref-type="bibr" rid="scirp.46550-ref9">9</xref>] , TBXA2R [<xref ref-type="bibr" rid="scirp.46550-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.46550-ref11">11</xref>] and VEGFA [<xref ref-type="bibr" rid="scirp.46550-ref12">12</xref>] genes. The ADRBK1 gene (also known as GRK2) is encoded on chromosome 11 and is expressed as a ubiquitous cytosolic enzyme that specifically phosphorylates the activated form of the beta-adrenergic and related G-protein-coupled receptors. Abnormal coupling of beta-adrenergic receptor to G protein is involved in the pathogenesis of the failing heart. The TBXA2R gene is encoded on chromosome 19 and is a member of the G protein-coupled receptor family. The protein interacts with thromboxane A2 to induce platelet aggregation and regulate hemostasis. The VEGFA gene is encoded on chromosome 6 and is usually expressed as a 46-kDa disulfide-linked homodimer. VEGFA is a signaling protein involved in the regulation of angiogenesis, vasculogenesis and endothelial cell growth. It induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels.</p><p>Single nucleotide changes that affect gene expression by impacting gene regulatory sequences such as promoters, enhances, and silencers are known as regulatory SNPs (rSNPs) [<xref ref-type="bibr" rid="scirp.46550-ref13">13</xref>] -[<xref ref-type="bibr" rid="scirp.46550-ref16">16</xref>] . A rSNPs within a transcriptional factor binding site (TFBS) can change a transcriptional factor’s (TF) ability to bind its TFBS [<xref ref-type="bibr" rid="scirp.46550-ref17">17</xref>] -[<xref ref-type="bibr" rid="scirp.46550-ref20">20</xref>] in which case the TF would be unable to effectively regulate its target gene [<xref ref-type="bibr" rid="scirp.46550-ref21">21</xref>] -[<xref ref-type="bibr" rid="scirp.46550-ref25">25</xref>] . This concept is examined for ADRBK1, TBXA2R and VEGFA rSNPs found in potential SP1 and KLF4 TFBS within these genes. These rSNPs within each gene have been reported to be in linkage disequilibrium (LD) [<xref ref-type="bibr" rid="scirp.46550-ref26">26</xref>] -[<xref ref-type="bibr" rid="scirp.46550-ref28">28</xref>] and this disequilibrium in conjunction with their SP1 and KLF4 TFBS were examined in this study. In this report LD is considered to be the non-random association of rSNP alleles within the gene.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>Identifying TFBS</title><p>The JASPAR CORE database [<xref ref-type="bibr" rid="scirp.46550-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.46550-ref30">30</xref>] and ConSite [<xref ref-type="bibr" rid="scirp.46550-ref31">31</xref>] were used to identify the KLF and SP TFBS in this study. JASPAR is a collection of transcription factor DNA-binding preferences used for scanning genomic sequences where ConSite is a web-based tool for finding cis-regulatory elements in genomic sequences. The TFBS and rSNP location within the binding sites have previously been discussed [<xref ref-type="bibr" rid="scirp.46550-ref32">32</xref>] . The Vector NTI Advance 11 computer program (Invitrogen, Life Technologies) was used to locate the TFBS in the ADRBK1 gene (NCBI Ref Seq NM_001619) from 12.78 kbp upstream of the transcriptional start site to 3 kbp past the 3’UTR which represents a total of 36 kbp.</p><p>The VNTI program was also used to locate TFBS in the TBXA2R gene (NCBI Ref Seq NM_201636) from 9.4 kb upstream of the transcriptional start site to 1.4 kb past the 3’UTR which represents a total of 17.1 Kbp and in the VEGFA gene gene (NCBI Ref Seq NM_ 001171626) from 2.2 kb upstream of exon one to 1.7 kb past the 3’UTR which represents a total of 19.6 Kbp. The JASPAR CORE database was also used to compute each nucleotide occurrence (%) within the TFBS where upper case lettering indicate that the nucleotide occurs 90% or greater and lower case less than 90%. The occurrence of each SNP allele in the TFBS is also computed from the database (<xref ref-type="table" rid="table1">Table 1</xref>).</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. ADRBK1 rSNPs and TFBS</title><p>The ADRBK1 gene transcribes GRK2 a serine/threonine kinase which is a ubiquitous cytosolic enzyme that specifically phosphorylates the activated form of the beta-adrenergic and related G-protein-coupled receptors. The rs948988 SNP common ADRBK1-G allele creates three TFBS for the KLF1, KLF4 and KLF5 TFs which are involved with erythrocyte development, activation and repression (<xref ref-type="table" rid="table1">Table 1</xref>). The rs4370946 SNP common ADRBK1-C allele creates TFBS for the KLF4, KLF5, SP1, and SP2 TFs which are involved with transcription activation and repression (<xref ref-type="table" rid="table1">Table 1</xref>). The minor alleles for the two rSNPs do not create any KLF or SP TFBS.</p></sec><sec id="s3_2"><title>3.2. TBXA2R rSNPs and TFBS</title><p>The TBXA2R gene encodes a member of the G protein-coupled receptor family and the protein interacts with</p><table-wrap id="table1"  position="float"><object-id pub-id-type="pii">Table 1</object-id><label>Table 1</label><caption><p>. ADRBK1, TBXA2R and VEGFA rSNPs that regulate KLF &amp; SP TFBS. Listed are the rSNPs, gene location, allele/ frequency, transcriptional factors (TFs) and protein name, number of times the TFBS are found in each gene. Where the upper case nucleotide occurs at least 90% of the time in the TFBS region and red is the SNP location. Also listed is the DNA strand orientation. Below the TFBS is the rSNP allele occurrence (%) obtained from the Jaspar Core database. Note: TFs can bind to more than one nucleotide sequence.</p></caption><table><thead><tr><th align="center" valign="middle" >GENE/SNP</th><th align="center" valign="middle" >Allele</th><th align="center" valign="middle" >TFs</th><th align="center" valign="middle" >Protein name</th><th align="center" valign="middle" ># of Sites</th><th align="center" valign="middle" >TFBS</th><th align="center" valign="middle" >Strand</th></tr></thead><tbody><tr><td align="center" valign="middle" >ADRBK1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >rs948988 (A/G)</td><td align="center" valign="middle" >G</td><td align="center" valign="middle" >KLF1</td><td align="center" valign="middle" >Kruppel-like factor 1 (erythroid)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >tgaCaCaCCga</td><td align="center" valign="middle" >minus</td></tr><tr><td align="center" valign="middle" >Intron 2</td><td align="center" valign="middle" >0.92</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >C = 100%</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >KLF4</td><td align="center" valign="middle" >Kruppel-like factor 4 (gut)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >tcGGtGtgtc</td><td align="center" valign="middle" >plus</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >G = 98%</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >KLF5</td><td align="center" valign="middle" >Kruppel-like factor 5 (intestinal)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >ccgaCtCCCc</td><td align="center" valign="middle" >minus</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >c = 87%</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >rs4370946 (C/T)</td><td align="center" valign="middle" >C</td><td align="center" valign="middle" >KLF4</td><td align="center" valign="middle" >Kruppel-like factor 4 (gut)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >tGGGaGcGgg</td><td align="center" valign="middle" >minus</td></tr><tr><td align="center" valign="middle" >3’UTR</td><td align="center" valign="middle" >0.92</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >G = 90%</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >KLF5</td><td align="center" valign="middle" >Kruppel-like factor 5 (intestinal)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >cccgCtCCCa</td><td align="center" valign="middle" >plus</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >c = 88%</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >SP1</td><td align="center" valign="middle" >Specificity Protein 1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >tgcCCgCtccc</td><td align="center" valign="middle" >plus</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >C = 99%</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >SP1</td><td align="center" valign="middle" >Specificity Protein 1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >cccgCtCCcag</td><td align="center" valign="middle" >plus</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >c = 77%</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >SP2</td><td align="center" valign="middle" >Specificity Protein 2</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >tgcCCgCtcccagtg</td><td align="center" valign="middle" >plus</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >C = 100%</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >TBXA2R</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >rs2238633 (A/C)</td><td align="center" valign="middle" >C</td><td align="center" valign="middle" >KLF4</td><td align="center" valign="middle" >Kruppel-like factor 4 (gut)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >aGGGtGgGgt</td><td align="center" valign="middle" >minus</td></tr><tr><td align="center" valign="middle" >Intron 1</td><td align="center" valign="middle" >0.83</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >G = 90%</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >SP1</td><td align="center" valign="middle" >Specificity Protein 1</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >CcCcacCctgc</td><td align="center" valign="middle" >plus</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >c = 86%</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >rs4523 (C/T)</td><td align="center" valign="middle" >T</td><td align="center" valign="middle" >KLF4</td><td align="center" valign="middle" >Kruppel-like factor 4 (gut)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >tGGGtGtata</td><td align="center" valign="middle" >minus</td></tr><tr><td align="center" valign="middle" >c.924T&gt;C</td><td align="center" valign="middle" >0.45</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >t = 7%</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Exon 3</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >rs5756 (C/T)</td><td align="center" valign="middle" >C</td><td align="center" valign="middle" >KLF4</td><td align="center" valign="middle" >Kruppel-like factor 4 (gut)</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >cGGGcGtggt</td><td align="center" valign="middle" >plus</td></tr><tr><td align="center" valign="middle" >3’UTR</td><td align="center" valign="middle" >0.63</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >G = 98%</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >VEGFA</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >rs1570360 (A/G)</td><td align="center" valign="middle" >G</td><td align="center" valign="middle" >KLF4</td><td align="center" valign="middle" >Kruppel-like factor 4 (gut)</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >gtGGaGgGGc</td><td align="center" valign="middle" >plus</td></tr><tr><td align="center" valign="middle" >Promoter</td><td align="center" valign="middle" >0.78</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >G = 98%</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >SP1</td><td align="center" valign="middle" >Specificity Protein 1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >CCCcTCCACA</td><td align="center" valign="middle" >minus</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >c = 77%</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >rs34357231 (D/I)</td><td align="center" valign="middle" >I</td><td align="center" valign="middle" >KLF5</td><td align="center" valign="middle" >Kruppel-like factor 5 (intestinal)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >gtccCaCtCt</td><td align="center" valign="middle" >plus</td></tr><tr><td align="center" valign="middle" >Promoter</td><td align="center" valign="middle" >0.28</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >KLF5</td><td align="center" valign="middle" >Kruppel-like factor 5 (intestinal)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >actcttCCCa</td><td align="center" valign="middle" >plus</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >SP1</td><td align="center" valign="middle" >Specificity Protein 1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >gtcCCaCtctt</td><td align="center" valign="middle" >plus</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >SP1</td><td align="center" valign="middle" >Specificity Protein 1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >actCttCCcac</td><td align="center" valign="middle" >plus</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="3"  >(I)nsertation = 18bp (GGTCCCACTCTTCCCACA)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>thromboxane A2 to induce platelet aggregation and regulate hemostasis. The activity of this receptor is mediated by a G-protein that activates a phosphatidylinositol-calcium second messenger system. The rs2238633 SNP TBXA2R-C allele in intron one creates two TFBS for the KLF4 and SP1 TFs which are involved in transcriptional regulation and repression. The rs4523 SNP TBXA2R-T allele in exon three and the rs5756 SNP TBXA2R-C allele in the 3’UTR each create one TFBS for the KLF4 TF. The other alleles for the three rSNPs do not create any KLF or SP TFBS.</p></sec><sec id="s3_3"><title>3.3. VEGFA rSNPs and TFBS</title><p>The VEGFA gene is a member of the PDGF/VEGF growth factor family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. The rs1570360 SNP VEGFA-G allele in the promoter at −1190 bp from the transcriptional start site (TSS) creates two TFBS for the KLF4 and SP1 TFs each in the same location but opposite strands of the DNA duplex (<xref ref-type="table" rid="table1">Table 1</xref>). The rs34357231 SNP is a 18bp insertion/deletion (I/D) polymorphism located in the promoter at −2549 bp from the TSS [<xref ref-type="bibr" rid="scirp.46550-ref33">33</xref>] . The rs34357231 SNP VEGFA-I allele creates TFBS for the KLF5 and SP1 TFs. The other alleles for the two rSNPs do not create any KLF or SP TFBS.</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>Genome-wide association studies (GWAS) over the last decade have identified nearly 6500 disease or trait- predisposing SNPs where only 7% of these are located in protein-coding regions of the genome [<xref ref-type="bibr" rid="scirp.46550-ref34">34</xref>] [<xref ref-type="bibr" rid="scirp.46550-ref35">35</xref>] and the remaining 93% are located within non-coding areas [<xref ref-type="bibr" rid="scirp.46550-ref36">36</xref>] [<xref ref-type="bibr" rid="scirp.46550-ref37">37</xref>] such as regulatory or intergenic regions. SNPs which occur in the putative regulatory region of a gene where a single base change in the DNA sequence of a potential TFBS may affect the process of gene expression are drawing more attention [<xref ref-type="bibr" rid="scirp.46550-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.46550-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.46550-ref38">38</xref>] . A SNP in a TFBS can have multiple consequences. Often the SNP does not change the TFBS interaction nor does it alter gene expression since a transcriptional factor (TF) will usually recognize a number of different binding sites in the gene. In some cases the SNP may increase or decrease the TF binding which results in allele-specific gene expression. In rare cases, a SNP may eliminate the natural binding site or generate a new binding site. In which cases the gene is no longer regulated by the original TF. Therefore, functional rSNPs in TFBS may result in differences in gene expression, phenotypes and susceptibility to environmental exposure [<xref ref-type="bibr" rid="scirp.46550-ref38">38</xref>] . Examples of rSNPs associated with disease susceptibility are numerous and several reviews have been published [<xref ref-type="bibr" rid="scirp.46550-ref38">38</xref>] -[<xref ref-type="bibr" rid="scirp.46550-ref41">41</xref>] .</p><p>In this study the rs948988 rSNP ADRBK1-G allele [G (+ strand) or C (− strand)] located in the KLF1, KLF4 and KLF5 TFBS have a 100%, 98% and 87% occurrence, respectively, and consequently have been reasonably well conserved in human evolution (<xref ref-type="table" rid="table1">Table 1</xref>). Each of the three potential KLF TFBS occur only one time in the gene (<xref ref-type="table" rid="table1">Table 1</xref>) and therefore the rSNP would probably have a great impact on the KLF TFs regulating the gene. The rs4370946 rSNP ADRBK1-C allele [C (+ strand) or G (− strand)] located in the two KLF and three SP TFBS have all been well conserved in human evolution ranging from 77 to 100% in occurrence (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>The rs2238633 rSNP TBXA2R-C allele [C (+ strand) or G (− strand)] located in the KLF4 and SP1 TFBS have a 90 and 86% occurrence, respectively, and have been well conserved in human evolution (<xref ref-type="table" rid="table1">Table 1</xref>). The KLF4 TFBS occurs once while the SP1 TFBS occurs twice in the gene. The rs4523 rSNP TBXA2R-T allele [T (- strand)] located in a KLF4 TFBS has a 7% occurrence and not well conserved in human evolution, therefore, probably would not have much impact on regulating the gene (<xref ref-type="table" rid="table1">Table 1</xref>). The rs5756 rSNP TBXA2R-C allele [C (− strand) or G (+ strand)] located in a KLF4 TFBS has a 98% occurrence in humans and this TFBS occurs four times in the gene (<xref ref-type="table" rid="table1">Table 1</xref>). The rs1570360 SNP VEGFA-G allele [G (+ strand) or C (− strand)] is a well conserved nucleotide (98%) in the TFBS for the KLF4 TF and moderately conserved (77%) in the TFBS for the SP1 TF. These potential TFBS occur twice and once in the gene, respectively. The rs34357231 SNP VEGFA- I allele has an insertion frequency of 0.28. All of the potential KLF5 and SP1 TFBS are created by the insertion and do not exist when the 18bp sequence is deleted.</p><p>When examining the table, it can be seen from the KLF4/SP1 TFBS representing the ADRBK1 (rs4370946), TBXA2R (rs2238633) and VEGFA (rs1570360) rSNPs that the KLF4 TF binds the duplex DNA on one strand while SP1 binds the DNA at the same location on the opposite strand which suggests that these two TFs may be involved in duplex DNA strand separation [<xref ref-type="bibr" rid="scirp.46550-ref42">42</xref>] [<xref ref-type="bibr" rid="scirp.46550-ref43">43</xref>] during transcription. Since these TFs potentially bind the DNA at the same location, a nucleotide change in their respective TFBS could affect their regulation of the respective genes.</p><p>LD between SNPs in the regulatory region of a gene can indicate strong associations of certain haplotypes with sickness or disease [<xref ref-type="bibr" rid="scirp.46550-ref28">28</xref>] . Consequently, an evaluation was made within the ADRBK1 [<xref ref-type="bibr" rid="scirp.46550-ref9">9</xref>] , TBXA2R [<xref ref-type="bibr" rid="scirp.46550-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.46550-ref11">11</xref>] and VEGFA [<xref ref-type="bibr" rid="scirp.46550-ref12">12</xref>] genes for the rSNPs in LD [<xref ref-type="bibr" rid="scirp.46550-ref26">26</xref>] and their effect on potential KLF/SP TFBS (Table). Since it has been shown that KLF4 and SP1 physically interact, occupy the angiotensin II type 1 receptor (AT1R) promoter and induce AT1R transcription in VSMCs in a co-operative manner under basal conditions [<xref ref-type="bibr" rid="scirp.46550-ref8">8</xref>] , the evaluation was based on these two TFs. The LD between the ADRBK1 rs948933 and rs437046 rSNPs may result from the lack of a SP1 TFBS regulated by rs948988 in intron two while there is a SP1 TFBS regulated by rs4370946 in the 3’UTR of the gene (<xref ref-type="table" rid="table1">Table 1</xref>). The LD between the TBXA2R rs2238633, rs4523 and rs5756 rSNPs may also result from the lack of a SP1 TFBS regulated by the rs4523 rSNP in exon three and by the rs5756 rSNP in the 3’UTR of the gene (<xref ref-type="table" rid="table1">Table 1</xref>). The LD between the VEGFA rs1570360 and rs34357231 rSNPs in the promoter may result from the lack of a KLF4 TFBS in the insertion region created by the rs34357231 rSNP. For KLF4 and SP1 TF interaction, there is another KLF4 TFBS upstream regulated by the rs1570360 rSNP. Since the alternate alleles of the above rSNPs do not create any KLF or SP TFBS, it can be assumed that haplotypes carrying rSNP alleles which create KLF and SP TFBS are essential in the regulation of these genes and could be responsible for the LD.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Single nucleotide changes in TF motifs have the ability to alter gene regulation and thereby result in disease. There are many reports appearing in the literature describing human disease and the association with SNPs [<xref ref-type="bibr" rid="scirp.46550-ref44">44</xref>] ; however, few of these reports are examining the SNP location for accompanying changes in TFBS that would affect gene regulation [<xref ref-type="bibr" rid="scirp.46550-ref45">45</xref>] . In the present study the SNPs in the regulatory region of the ADRBK1, TBXA2R and VEGFA genes can alter the KLF and SP1 binding sites rendering these TFs unable to regulate these genes.</p></sec><sec id="s6"><title>Dedication</title><p>This manuscript is dedicated to the memory of Richard M. Buroker.</p></sec></body><back><ref-list><title>References</title><ref id="scirp.46550-ref1"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>NEMER</surname><given-names> M. </given-names></name>,<name name-style="western"><surname> HORB</surname><given-names> M.E. </given-names></name>,<etal>et al</etal>. (<year>2007</year>)<article-title>THE KLF FAMILY OF TRANSCRIPTIONAL REGULATORS IN CARDIOMYOCYTE PROLIFERATION AND DIFFERENTIATION</article-title><source> CELL CYCLE</source><volume> 6</volume>,<fpage> 117</fpage>-<lpage>121</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.4161/CC.6.2.3718</pub-id></mixed-citation></ref><ref id="scirp.46550-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">LIU, Y., ZHANG, C., FAN, J., XIAO, L., YIN, B., ZHOU, L. AND XIA, S. (2011) COMPREHENSIVE ANALYSIS OF CLINICAL SIGNIFICANCE OF STEM-CELL RELATED FACTORS IN RENAL CELL CANCER. WORLD JOURNAL OF SURGICAL ONCOLOGY, 9, 121. HTTP://DX.DOI.ORG/10.1186/1477-7819-9-121</mixed-citation></ref><ref id="scirp.46550-ref3"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>TAKAHASHI</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> TANABE</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> OHNUKI</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> NARITA</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> ICHISAKA</surname><given-names> T.</given-names></name>,<name name-style="western"><surname> TOMODA</surname><given-names> K. </given-names></name>,<name name-style="western"><surname> YAMANAKA</surname><given-names> S. </given-names></name>,<etal>et al</etal>. (<year>2007</year>)<article-title>INDUCTION OF PLURIPOTENT STEM CELLS FROM ADULT HUMAN FIBROBLASTS BY DEFINED FACTORS</article-title><source> CELL</source><volume> 131</volume>,<fpage> 861</fpage>-<lpage>872</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1016/J.CELL.2007.11.019</pub-id></mixed-citation></ref><ref id="scirp.46550-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">SUZUKI, T., AIZAWA, K., MATSUMURA, T. AND NAGAI, R. (2005) VASCULAR IMPLICATIONS OF THE KRUPPEL-LIKE FAMILY OF TRANSCRIPTION FACTORS. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, 25, 1135-1141. HTTP://DX.DOI.ORG/10.1161/01.ATV.0000165656.65359.23</mixed-citation></ref><ref id="scirp.46550-ref5"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>KALRA</surname><given-names> I.S.</given-names></name>,<name name-style="western"><surname> ALAM</surname><given-names> M.M.</given-names></name>,<name name-style="western"><surname> CHOUDHARY</surname><given-names> P.K. </given-names></name>,<name name-style="western"><surname> PACE</surname><given-names> B.S. </given-names></name>,<etal>et al</etal>. (<year>2011</year>)<article-title>KRUPPEL-LIKE FACTOR 4 ACTIVATES HBG GENE EXPRESSION IN PRIMARY ERYTHROID CELLS</article-title><source> BRITISH JOURNAL OF HAEMATOLOGY</source><volume> 154</volume>,<fpage> 248</fpage>-<lpage>259</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1111/J.1365-2141.2011.08710.X</pub-id></mixed-citation></ref><ref id="scirp.46550-ref6"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SHI</surname><given-names> J.H.</given-names></name>,<name name-style="western"><surname> ZHENG</surname><given-names> B.</given-names></name>,<name name-style="western"><surname> CHEN</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> MA</surname><given-names> G.Y. </given-names></name>,<name name-style="western"><surname> WEN</surname><given-names> J.K. </given-names></name>,<etal>et al</etal>. (<year>2012</year>)<article-title>RETINOIC ACID RECEPTOR ALPHA MEDIATES ALL-TRANS RETINOIC ACID-INDUCED KLF4 GENE EXPRESSION BY REGULATING KLF4 PROMOTER ACTIVITY IN VASCULAR SMOOTH MUSCLE CELLS</article-title><source> THE JOURNAL OF BIOLOGICAL CHEMISTRY</source><volume> 287</volume>,<fpage> 10799</fpage>-<lpage>10811</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1074/JBC.M111.321836</pub-id></mixed-citation></ref><ref id="scirp.46550-ref7"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>EVANS</surname><given-names> P.M. </given-names></name>,<name name-style="western"><surname> LIU</surname><given-names> C. </given-names></name>,<etal>et al</etal>. (<year>2008</year>)<article-title>ROLES OF KRUPEL-LIKE FACTOR 4 IN NORMAL HOMEOSTASIS, CANCER AND STEM CELLS</article-title><source> ACTA BIOCHIMICA ET BIOPHYSICA SINICA</source><volume> 40</volume>,<fpage> 554</fpage>-<lpage>564</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1111/J.1745-7270.2008.00439.X</pub-id></mixed-citation></ref><ref id="scirp.46550-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">ZHANG, X.H., ZHENG, B., GU, C., FU, J.R. AND WEN, J.K. (2012) TGF-BETA1 DOWNREGULATES AT1 RECEPTOR EXPRESSION VIA PKC-DELTA-MEDIATED SP1 DISSOCIATION FROM KLF4 AND SMAD-MEDIATED PPAR-GAMMA ASSOCIATION WITH KLF4. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, 32, 1015-1023. HTTP://DX.DOI.ORG/10.1161/ATVBAHA.111.244962</mixed-citation></ref><ref id="scirp.46550-ref9"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>PENN</surname><given-names> R.B. </given-names></name>,<name name-style="western"><surname> BENOVIC</surname><given-names> J.L. </given-names></name>,<etal>et al</etal>. (<year>1994</year>)<article-title>PENN, R.B. AND BENOVIC, J.L.  STRUCTURE OF THE HUMAN GENE ENCODING THE BETA-ADRENERGIC RECEPTOR KINASE</article-title><source> THE JOURNAL OF BIOLOGICAL CHEMISTRY</source><volume> 269</volume>,<fpage> 14924</fpage>-<lpage>14930</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.46550-ref10"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>GANNON</surname><given-names> A.M. </given-names></name>,<name name-style="western"><surname> KINSELLA</surname><given-names> B.T. </given-names></name>,<etal>et al</etal>. (<year>2008</year>)<article-title>REGULATION OF THE HUMAN THROMBOXANE A2 RECEPTOR GENE BY SP1, EGR1, NF-E2, GATA-1, AND ETS-1 IN MEGAKARYOCYTES</article-title><source> THE JOURNAL OF LIPID RESEARCH</source><volume> 49</volume>,<fpage> 2590</fpage>-<lpage>2604</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1194/JLR.M800256-JLR200</pub-id></mixed-citation></ref><ref id="scirp.46550-ref11"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>GANNON</surname><given-names> A.M.</given-names></name>,<name name-style="western"><surname> TURNER</surname><given-names> E.C.</given-names></name>,<name name-style="western"><surname> REID</surname><given-names> H.M. </given-names></name>,<name name-style="western"><surname> KINSELLA</surname><given-names> B.T. </given-names></name>,<etal>et al</etal>. (<year>2009</year>)<article-title>REGULATED EXPRESSION OF THE ALPHA ISOFORM OF THE HUMAN THROMBOXANE A2 RECEPTOR DURING MEGAKARYOCYTE DIFFERENTIATION: A COORDINATED ROLE FOR WT1, EGR1, AND SP1</article-title><source> JOURNAL OF MOLECULAR BIOLOGY</source><volume> 394</volume>,<fpage> 29</fpage>-<lpage>45</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1016/J.JMB.2009.09.007</pub-id></mixed-citation></ref><ref id="scirp.46550-ref12"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>ABDELRAHIM</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> SMITH 3RD</surname><given-names> R.</given-names></name>,<name name-style="western"><surname> BURGHARDT</surname><given-names> R. </given-names></name>,<name name-style="western"><surname> SAFE</surname><given-names> S. </given-names></name>,<etal>et al</etal>. (<year>2004</year>)<article-title>ROLE OF SP PROTEINS IN REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION AND PROLIFERATION OF PANCREATIC CANCER CELLS</article-title><source> CANCER RESEARCH</source><volume> 64</volume>,<fpage> 6740</fpage>-<lpage>6749</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1158/0008-5472.CAN-04-0713</pub-id></mixed-citation></ref><ref id="scirp.46550-ref13"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>KNIGHT</surname><given-names> J.C. </given-names></name>,<etal>et al</etal>. (<year>2003</year>)<article-title>FUNCTIONAL IMPLICATIONS OF GENETIC VARIATION IN NON-CODING DNA FOR DISEASE SUSCEPTIBILITY AND GENE REGULATION</article-title><source> CLINICAL SCIENCE</source><volume> 104</volume>,<fpage> 493</fpage>-<lpage>501</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1042/CS20020304</pub-id></mixed-citation></ref><ref id="scirp.46550-ref14"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>KNIGHT</surname><given-names> J.C. </given-names></name>,<etal>et al</etal>. (<year>2005</year>)<article-title>REGULATORY POLYMORPHISMS UNDERLYING COMPLEX DISEASE TRAITS</article-title><source> JOURNAL OF MOLECULAR MEDICINE</source><volume> 83</volume>,<fpage> 97</fpage>-<lpage>109</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1007/S00109-004-0603-7</pub-id></mixed-citation></ref><ref id="scirp.46550-ref15"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>WANG</surname><given-names> X.</given-names></name>,<name name-style="western"><surname> TOMSO</surname><given-names> D.J.</given-names></name>,<name name-style="western"><surname> LIU</surname><given-names> X. </given-names></name>,<name name-style="western"><surname> BELL</surname><given-names> D.A. </given-names></name>,<etal>et al</etal>. (<year>2005</year>)<article-title>SINGLE NUCLEOTIDE POLYMORPHISM IN TRANSCRIPTIONAL REGULATORY REGIONS AND EXPRESSION OF ENVIRONMENTALLY RESPONSIVE GENES</article-title><source> TOXICOLOGY AND APPLIED PHARMACOLOGY</source><volume> 207</volume>,<fpage> 84</fpage>-<lpage>90</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1016/J.TAAP.2004.09.024</pub-id></mixed-citation></ref><ref id="scirp.46550-ref16"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>WANG</surname><given-names> X.</given-names></name>,<name name-style="western"><surname> TOMSO</surname><given-names> D.J.</given-names></name>,<name name-style="western"><surname> CHORLEY</surname><given-names> B.N.</given-names></name>,<name name-style="western"><surname> CHO</surname><given-names> H.Y.</given-names></name>,<name name-style="western"><surname> CHEUNG</surname><given-names> V.G.</given-names></name>,<name name-style="western"><surname> KLEEBERGER</surname><given-names> S.R. </given-names></name>,<name name-style="western"><surname> BELL</surname><given-names> D.A. </given-names></name>,<etal>et al</etal>. (<year>2007</year>)<article-title>IDENTIFICATION OF POLYMORPHIC ANTIOXIDANT RESPONSE ELEMENTS IN THE HUMAN GENOME</article-title><source> HUMAN MOLECULAR GENETICS</source><volume> 16</volume>,<fpage> 1188</fpage>-<lpage>1200</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1093/HMG/DDM066</pub-id></mixed-citation></ref><ref id="scirp.46550-ref17"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>CLAESSENS</surname><given-names> F.</given-names></name>,<name name-style="western"><surname> VERRIJDT</surname><given-names> G.</given-names></name>,<name name-style="western"><surname> SCHOENMAKERS</surname><given-names> E.</given-names></name>,<name name-style="western"><surname> HAELENS</surname><given-names> A.</given-names></name>,<name name-style="western"><surname> PEETERS</surname><given-names> B.</given-names></name>,<name name-style="western"><surname> VERHOEVEN</surname><given-names> G. </given-names></name>,<name name-style="western"><surname> ROMBAUTS</surname><given-names> W. </given-names></name>,<etal>et al</etal>. (<year>2001</year>)<article-title>CLAESSENS, F., VERRIJDT, G., SCHOENMAKERS, E., HAELENS, A., PEETERS, B., VERHOEVEN, G. AND ROMBAUTS, W.  SELECTIVE DNA BINDING BY THE ANDROGEN RECEPTOR AS A MECHANISM FOR HORMONE-SPECIFIC GENE REGULATION</article-title><source> THE JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY</source><volume> 76</volume>,<fpage> 23</fpage>-<lpage>30</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.46550-ref18"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>HSU</surname><given-names> M.H.</given-names></name>,<name name-style="western"><surname> SAVAS</surname><given-names> U.</given-names></name>,<name name-style="western"><surname> GRIFFIN</surname><given-names> K.J. </given-names></name>,<name name-style="western"><surname> JOHNSON</surname><given-names> E.F. </given-names></name>,<etal>et al</etal>. (<year>2007</year>)<article-title>REGULATION OF HUMAN CYTOCHROME P450 4F2 EXPRESSION BY STEROL REGULATORY ELEMENT-BINDING PROTEIN AND LOVASTATIN</article-title><source> THE JOURNAL OF BIOLOGICAL CHEMISTRY</source><volume> 282</volume>,<fpage> 5225</fpage>-<lpage>5236</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1074/JBC.M608176200</pub-id></mixed-citation></ref><ref id="scirp.46550-ref19"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>TAKAI</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> ARAKI</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> MEZAWA</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> KIM</surname><given-names> D.S.</given-names></name>,<name name-style="western"><surname> LI</surname><given-names> X.</given-names></name>,<name name-style="western"><surname> YANG</surname><given-names> L.</given-names></name>,<name name-style="western"><surname> LI</surname><given-names> Z.</given-names></name>,<name name-style="western"><surname> WANG</surname><given-names> Z.</given-names></name>,<name name-style="western"><surname> NAKAYAMA</surname><given-names> Y. </given-names></name>,<name name-style="western"><surname> OGATA</surname><given-names> Y. </given-names></name>,<etal>et al</etal>. (<year>2008</year>)<article-title>AP1 BINDING SITE IS ANOTHER TARGET OF FGF2 REGULATION OF BONE SIALOPROTEIN GENE TRANSCRIPTION</article-title><source> GENE</source><volume> 410</volume>,<fpage> 97</fpage>-<lpage>104</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1016/J.GENE.2007.11.017</pub-id></mixed-citation></ref><ref id="scirp.46550-ref20"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>BUROKER</surname><given-names> N.E.</given-names></name>,<name name-style="western"><surname> HUANG</surname><given-names> J.Y.</given-names></name>,<name name-style="western"><surname> BARBOZA</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> LEDEE</surname><given-names> D.R.</given-names></name>,<name name-style="western"><surname> EASTMAN JR.</surname><given-names> R.J.</given-names></name>,<name name-style="western"><surname> REINECKE</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> NING</surname><given-names> X.H.</given-names></name>,<name name-style="western"><surname> BASSUK</surname><given-names> J.A. </given-names></name>,<name name-style="western"><surname> PORTMAN</surname><given-names> M.A. </given-names></name>,<etal>et al</etal>. (<year>2012</year>)<article-title>THE ADAPTOR-RELATED PROTEIN COMPLEX 2, ALPHA 2 SUBUNIT (AP2ALPHA2) GENE IS A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR CARDIAC TARGET GENE</article-title><source> THE PROTEIN JOURNAL</source><volume> 31</volume>,<fpage> 75</fpage>-<lpage>83</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1007/S10930-011-9379-0</pub-id></mixed-citation></ref><ref id="scirp.46550-ref21"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>HUANG</surname><given-names> C.N.</given-names></name>,<name name-style="western"><surname> HUANG</surname><given-names> S.P.</given-names></name>,<name name-style="western"><surname> PAO</surname><given-names> J.B.</given-names></name>,<name name-style="western"><surname> HOUR</surname><given-names> T.C.</given-names></name>,<name name-style="western"><surname> CHANG</surname><given-names> T.Y.</given-names></name>,<name name-style="western"><surname> LAN</surname><given-names> Y.H.</given-names></name>,<name name-style="western"><surname> LU</surname><given-names> T.L.</given-names></name>,<name name-style="western"><surname> LEE</surname><given-names> H.Z.</given-names></name>,<name name-style="western"><surname> JUANG</surname><given-names> S.H.</given-names></name>,<name name-style="western"><surname> WU</surname><given-names> P.P.</given-names></name>,<name name-style="western"><surname> HUANG</surname><given-names> C.Y.</given-names></name>,<name name-style="western"><surname> HSIEH</surname><given-names> C.J. </given-names></name>,<name name-style="western"><surname> BAO</surname><given-names> B.Y. </given-names></name>,<etal>et al</etal>. (<year>2012</year>)<article-title>GENETIC POLYMORPHISMS IN OESTROGEN RECEPTOR-BINDING SITES AFFECT CLINICAL OUTCOMES IN PATIENTS WITH PROSTATE CANCER RECEIVING ANDROGEN-DEPRIVATION THERAPY</article-title><source> JOURNAL OF INTERNAL MEDICINE</source><volume> 271</volume>,<fpage> 499</fpage>-<lpage>509</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1111/J.1365-2796.2011.02449.X</pub-id></mixed-citation></ref><ref id="scirp.46550-ref22"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>HUANG</surname><given-names> C.N.</given-names></name>,<name name-style="western"><surname> HUANG</surname><given-names> S.P.</given-names></name>,<name name-style="western"><surname> PAO</surname><given-names> J.B.</given-names></name>,<name name-style="western"><surname> CHANG</surname><given-names> T.Y.</given-names></name>,<name name-style="western"><surname> LAN</surname><given-names> Y.H.</given-names></name>,<name name-style="western"><surname> LU</surname><given-names> T.L.</given-names></name>,<name name-style="western"><surname> LEE</surname><given-names> H.Z.</given-names></name>,<name name-style="western"><surname> JUANG</surname><given-names> S.H.</given-names></name>,<name name-style="western"><surname> WU</surname><given-names> P.P.</given-names></name>,<name name-style="western"><surname> PU</surname><given-names> Y.S.</given-names></name>,<name name-style="western"><surname> HSIEH</surname><given-names> C.J. </given-names></name>,<name name-style="western"><surname> BAO</surname><given-names> B.Y. </given-names></name>,<etal>et al</etal>. (<year>2012</year>)<article-title>HUANG, C.N., HUANG, S.P., PAO, J.B., CHANG, T.Y., LAN, Y.H., LU, T.L., LEE, H.Z., JUANG, S.H., WU, P.P., PU, Y.S., HSIEH, C.J. AND BAO, B.Y.  GENETIC POLYMORPHISMS IN ANDROGEN RECEPTOR-BINDING SITES PREDICT SURVIVAL IN PROSTATE CANCER PATIENTS RECEIVING ANDROGEN-DEPRIVATION THERAPY</article-title><source> ANNALS OF ONCOLOGY: OFFICIAL JOURNAL OF THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY/ESMO</source><volume> 23</volume>,<fpage> 707</fpage>-<lpage>713</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.46550-ref23"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>YU</surname><given-names> B.</given-names></name>,<name name-style="western"><surname> LIN</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> YANG</surname><given-names> L.</given-names></name>,<name name-style="western"><surname> CHEN</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> LUO</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> LIU</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> GAO</surname><given-names> X.</given-names></name>,<name name-style="western"><surname> XIA</surname><given-names> X. </given-names></name>,<name name-style="western"><surname> HUANG</surname><given-names> Z. </given-names></name>,<etal>et al</etal>. (<year>2012</year>)<article-title>GENETIC VARIATION IN THE NRF2 PROMOTER ASSOCIATES WITH DEFECTIVE SPERMATOGENESIS IN HUMANS</article-title><source> JOURNAL OF MOLECULAR MEDICINE</source><volume> 2012</volume>,<fpage> 1333</fpage>-<lpage>1342</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1007/S00109-012-0914-Z</pub-id></mixed-citation></ref><ref id="scirp.46550-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">WU, J., RICHARDS, M.H., HUANG, J., AL-HARTHI, L., XU, X., LIN, R., XIE, F., GIBSON, A.W., EDBERG, J.C. AND KIMBERLY, R.P. (2011) HUMAN FASL GENE IS A TARGET OF BETA-CATENIN/T-CELL FACTOR PATHWAY AND COMPLEX FASL HAPLOTYPES ALTER PROMOTER FUNCTIONS. PLOS ONE, 6, E26143. HTTP://DX.DOI.ORG/10.1371/JOURNAL.PONE.0026143</mixed-citation></ref><ref id="scirp.46550-ref25"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>ALAM</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> PRAVICA</surname><given-names> V.</given-names></name>,<name name-style="western"><surname> FRYER</surname><given-names> A.A.</given-names></name>,<name name-style="western"><surname> HAWKINS</surname><given-names> C.P. </given-names></name>,<name name-style="western"><surname> HUTCHINSON</surname><given-names> I.V. </given-names></name>,<etal>et al</etal>. (<year>2005</year>)<article-title>NOVEL POLYMORPHISM IN THE PROMOTER REGION OF THE HUMAN NERVE GROWTH-FACTOR GENE</article-title><source> INTERNATIONAL JOURNAL OF IMMUNOGENETICS</source><volume> 32</volume>,<fpage> 379</fpage>-<lpage>382</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1111/J.1744-313X.2005.00541.X</pub-id></mixed-citation></ref><ref id="scirp.46550-ref26"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>LOBMEYER</surname><given-names> M.T.</given-names></name>,<name name-style="western"><surname> WANG</surname><given-names> L.</given-names></name>,<name name-style="western"><surname> ZINEH</surname><given-names> I.</given-names></name>,<name name-style="western"><surname> TURNER</surname><given-names> S.T.</given-names></name>,<name name-style="western"><surname> GUMS</surname><given-names> J.G.</given-names></name>,<name name-style="western"><surname> CHAPMAN</surname><given-names> A.B.</given-names></name>,<name name-style="western"><surname> COOPER-DEHOFF</surname><given-names> R.M.</given-names></name>,<name name-style="western"><surname> BEITELSHEES</surname><given-names> A.L.</given-names></name>,<name name-style="western"><surname> BAILEY</surname><given-names> K.R.</given-names></name>,<name name-style="western"><surname> BOERWINKLE</surname><given-names> E.</given-names></name>,<name name-style="western"><surname> PEPINE</surname><given-names> C.J. </given-names></name>,<name name-style="western"><surname> JOHNSON</surname><given-names> J.A. </given-names></name>,<etal>et al</etal>. (<year>2011</year>)<article-title>POLYMORPHISMS IN GENES CODING FOR GRK2 AND GRK5 AND RESPONSE DIFFERENCES IN ANTIHYPERTENSIVE-TREATED PATIENTS</article-title><source> PHARMACOGENETICS AND GENOMICS</source><volume> 21</volume>,<fpage> 42</fpage>-<lpage>49</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1097/FPC.0B013E328341E911</pub-id></mixed-citation></ref><ref id="scirp.46550-ref27"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>TAKEUCHI</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> MASHIMO</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> SHIMOJO</surname><given-names> N.</given-names></name>,<name name-style="western"><surname> ARIMA</surname><given-names> T.</given-names></name>,<name name-style="western"><surname> INOUE</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> MORITA</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> SATO</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> SUZUKI</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> NISHIMUTA</surname><given-names> T.</given-names></name>,<name name-style="western"><surname> WATANABE</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> HOSHIOKA</surname><given-names> A.</given-names></name>,<name name-style="western"><surname> TOMIITA</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> YAMAIDE</surname><given-names> A.</given-names></name>,<name name-style="western"><surname> WATANABE</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> OKAMOTO</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> KOHNO</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> HATA</surname><given-names> A. </given-names></name>,<name name-style="western"><surname> SUZUKI</surname><given-names> Y. </given-names></name>,<etal>et al</etal>. (<year>2013</year>)<article-title>FUNCTIONAL VARIANTS IN THE THROMBOXANE A2 RECEPTOR GENE ARE ASSOCIATED WITH LUNG FUNCTION IN CHILDHOOD-ONSET ASTHMA</article-title><source> CLINICAL &amp; EXPERIMENTAL ALLERGY</source><volume> 43</volume>,<fpage> 413</fpage>-<lpage>424</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1111/CEA.12058</pub-id></mixed-citation></ref><ref id="scirp.46550-ref28"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>BUROKER</surname><given-names> N.E.</given-names></name>,<name name-style="western"><surname> NING</surname><given-names> X.H.</given-names></name>,<name name-style="western"><surname> ZHOU</surname><given-names> Z.N.</given-names></name>,<name name-style="western"><surname> LI</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> CEN</surname><given-names> W.J.</given-names></name>,<name name-style="western"><surname> WU</surname><given-names> X.F.</given-names></name>,<name name-style="western"><surname> ZHU</surname><given-names> W.Z.</given-names></name>,<name name-style="western"><surname> SCOTT</surname><given-names> C.R. </given-names></name>,<name name-style="western"><surname> CHEN</surname><given-names> S.H. </given-names></name>,<etal>et al</etal>. (<year>2013</year>)<article-title>BUROKER, N.E., NING, X.H., ZHOU, Z.N., LI, K., CEN, W.J., WU, X.F., ZHU, W.Z., SCOTT, C.R. AND CHEN, S.H.  VEGFA SNPS AND TRANSCRIPTIONAL FACTOR BINDING SITES ASSOCIATED WITH HIGH ALTITUDE SICKNESS IN HAN AND TIBETAN CHINESE AT THE QINGHAI-TIBETAN PLATEAU</article-title><source> THE JOURNAL OF PHYSIOLOGICAL SCIENCES</source><volume> 63</volume>,<fpage> 183</fpage>-<lpage>193</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.46550-ref29"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>BRYNE</surname><given-names> J.C.</given-names></name>,<name name-style="western"><surname> VALEN</surname><given-names> E.</given-names></name>,<name name-style="western"><surname> TANG</surname><given-names> M.H.</given-names></name>,<name name-style="western"><surname> MARSTR</surname><given-names></given-names></name>,<name name-style="western"><surname> T.</surname><given-names> WINTHER</given-names></name>,<name name-style="western"><surname> O.</surname><given-names> DA PIEDADE</given-names></name>,<name name-style="western"><surname> I.</surname><given-names> KROGH</given-names></name>,<name name-style="western"><surname> A.</surname><given-names> LENHARD</given-names></name>,<name name-style="western"><surname> B. </surname><given-names> S</given-names></name>,<name name-style="western"><surname>ELIN</surname><given-names> A. </given-names></name>,<etal>et al</etal>. (<year>2008</year>)<article-title>BRYNE, J.C., VALEN, E., TANG, M.H., MARSTRAND, T., WINTHER, O., DA PIEDADE, I., KROGH, A., LENHARD, B. AND SANDELIN, A.  JASPAR, THE OPEN ACCESS DATABASE OF TRANSCRIPTION FACTOR-BINDING PROFILES: NEW CONTENT AND TOOLS IN THE 2008 UPDATE</article-title><source> NUCLEIC ACIDS RESEARCH</source><volume> 36</volume>,<fpage> D102</fpage>-<lpage>D106</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.46550-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">SANDELIN, A., ALKEMA, W., ENGSTROM, P., WASSERMAN, W.W. AND LENHARD, B. (2004) JASPAR: AN OPEN-ACCESS DATABASE FOR EUKARYOTIC TRANSCRIPTION FACTOR BINDING PROFILES. NUCLEIC ACIDS RESEARCH, 32, D91-94.</mixed-citation></ref><ref id="scirp.46550-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">SANDELIN, A., WASSERMAN, W.W. AND LENHARD, B. (2004) CONSITE: WEB-BASED PREDICTION OF REGULATORY ELEMENTS USING CROSS-SPECIES COMPARISON. NUCLEIC ACIDS RESEARCH, 32, W249-W252.</mixed-citation></ref><ref id="scirp.46550-ref32"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>BUROKER</surname><given-names> N.E.</given-names></name>,<name name-style="western"><surname> NING</surname><given-names> X.H.</given-names></name>,<name name-style="western"><surname> ZHOU</surname><given-names> Z.N.</given-names></name>,<name name-style="western"><surname> LI</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> CEN</surname><given-names> W.J.</given-names></name>,<name name-style="western"><surname> WU</surname><given-names> X.F.</given-names></name>,<name name-style="western"><surname> ZHU</surname><given-names> W.Z.</given-names></name>,<name name-style="western"><surname> SCOTT</surname><given-names> C.R. </given-names></name>,<name name-style="western"><surname> CHEN</surname><given-names> S.H. </given-names></name>,<etal>et al</etal>. (<year>2012</year>)<article-title>AKT3, ANGPTL4, ENOS3, AND VEGFA ASSOCIATIONS WITH HIGH ALTITUDE SICKNESS IN HAN AND TIBETAN CHINESE AT THE QINGHAI-TIBETAN PLATEAU</article-title><source> INTERNATIONAL JOURNAL OF HEMATOLOGY</source><volume> 96</volume>,<fpage> 200</fpage>-<lpage>213</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1007/S12185-012-1117-7</pub-id></mixed-citation></ref><ref id="scirp.46550-ref33"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>BROGAN</surname><given-names> I.J.</given-names></name>,<name name-style="western"><surname> KHAN</surname><given-names> N.</given-names></name>,<name name-style="western"><surname> ISAAC</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> HUTCHINSON</surname><given-names> J.A.</given-names></name>,<name name-style="western"><surname> PRAVICA</surname><given-names> V. </given-names></name>,<name name-style="western"><surname> HUTCHINSON</surname><given-names> I.V. </given-names></name>,<etal>et al</etal>. (<year>1999</year>)<article-title>NOVEL POLYMORPHISMS IN THE PROMOTER AND 5’ UTR REGIONS OF THE HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR GENE</article-title><source> HUMAN IMMUNOLOGY</source><volume> 60</volume>,<fpage> 1245</fpage>-<lpage>1249</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1016/S0198-8859(99)00132-9</pub-id></mixed-citation></ref><ref id="scirp.46550-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">PENNISI, E. (2011) THE BIOLOGY OF GENOMES. DISEASE RISK LINKS TO GENE REGULATION. SCIENCE, 332, 1031. HTTP://DX.DOI.ORG/10.1126/SCIENCE.332.6033.1031</mixed-citation></ref><ref id="scirp.46550-ref35"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>KUMAR</surname><given-names> V.</given-names></name>,<name name-style="western"><surname> WIJMENGA</surname><given-names> C. </given-names></name>,<name name-style="western"><surname> WITHOFF</surname><given-names> S. </given-names></name>,<etal>et al</etal>. (<year>2012</year>)<article-title>FROM GENOME-WIDE ASSOCIATION STUDIES TO DISEASE MECHANISMS: CELIAC DISEASE AS A MODEL FOR AUTOIMMUNE DISEASES</article-title><source> SEMINARS IN IMMUNOPATHOLOGY</source><volume> 34</volume>,<fpage> 567</fpage>-<lpage>580</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1007/S00281-012-0312-1</pub-id></mixed-citation></ref><ref id="scirp.46550-ref36"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>HINDORFF</surname><given-names> L.A.</given-names></name>,<name name-style="western"><surname> SETHUPATHY</surname><given-names> P.</given-names></name>,<name name-style="western"><surname> JUNKINS</surname><given-names> H.A.</given-names></name>,<name name-style="western"><surname> RAMOS</surname><given-names> E.M.</given-names></name>,<name name-style="western"><surname> MEHTA</surname><given-names> J.P.</given-names></name>,<name name-style="western"><surname> COLLINS</surname><given-names> F.S. </given-names></name>,<name name-style="western"><surname> MANOLIO</surname><given-names> T.A. </given-names></name>,<etal>et al</etal>. (<year>2009</year>)<article-title>POTENTIAL ETIOLOGIC AND FUNCTIONAL IMPLICATIONS OF GENOME-WIDE ASSOCIATION LOCI FOR HUMAN DISEASES AND TRAITS</article-title><source> PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA</source><volume> 106</volume>,<fpage> 9362</fpage>-<lpage>9367</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1073/PNAS.0903103106</pub-id></mixed-citation></ref><ref id="scirp.46550-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">KUMAR, V., WESTRA, H.J., KARJALAINEN, J., ZHERNAKOVA, D.V., ESKO, T., HRDLICKOVA, B., ALMEIDA, R., ZHERNAKOVA, A., REINMAA, E., VOSA, U., HOFKER, M.H., FEHRMANN, R.S., FU, J., WITHOFF, S., METSPALU, A., FRANKE, L. AND WIJMENGA, C. (2013) HUMAN DISEASE-ASSOCIATED GENETIC VARIATION IMPACTS LARGE INTERGENIC NON-CODING RNA EXPRESSION. PLOS GENETICS, 9, E1003201. HTTP://DX.DOI.ORG/10.1371/JOURNAL.PGEN.1003201</mixed-citation></ref><ref id="scirp.46550-ref38"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>CHORLEY</surname><given-names> B.N.</given-names></name>,<name name-style="western"><surname> WANG</surname><given-names> X.</given-names></name>,<name name-style="western"><surname> CAMPBELL</surname><given-names> M.R.</given-names></name>,<name name-style="western"><surname> PITTMAN</surname><given-names> G.S.</given-names></name>,<name name-style="western"><surname> NOUREDDINE</surname><given-names> M.A. </given-names></name>,<name name-style="western"><surname> BELL</surname><given-names> D.A. </given-names></name>,<etal>et al</etal>. (<year>2008</year>)<article-title>DISCOVERY AND VERIFICATION OF FUNCTIONAL SINGLE NUCLEOTIDE POLYMORPHISMS IN REGULATORY GENOMIC REGIONS: CURRENT AND DEVELOPING TECHNOLOGIES</article-title><source> MUTATION RESEARCH</source><volume> 659</volume>,<fpage> 147</fpage>-<lpage>157</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1016/J.MRREV.2008.05.001</pub-id></mixed-citation></ref><ref id="scirp.46550-ref39"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>PROKUNINA</surname><given-names> L. </given-names></name>,<name name-style="western"><surname> ALARCON-RIQUELME</surname><given-names> M.E. </given-names></name>,<etal>et al</etal>. (<year>2004</year>)<article-title>REGULATORY SNPS IN COMPLEX DISEASES: THEIR IDENTIFICATION AND FUNCTIONAL VALIDATION</article-title><source> EXPERT REVIEWS IN MOLECULAR MEDICINE</source><volume> 6</volume>,<fpage> 1</fpage>-<lpage>15</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1017/S1462399404007690</pub-id></mixed-citation></ref><ref id="scirp.46550-ref40"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>BUCKL</surname><given-names></given-names></name>,<name name-style="western"><surname> P.R. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2006</year>)<article-title>THE IMPORTANCE AND IDENTIFICATION OF REGULATORY POLYMORPHISMS AND THEIR MECHANISMS OF ACTION</article-title><source> BIOCHIMICA ET BIOPHYSICA ACTA</source><volume> 1762</volume>,<fpage> 17</fpage>-<lpage>28</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1016/J.BBADIS.2005.10.004</pub-id></mixed-citation></ref><ref id="scirp.46550-ref41"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SADEE</surname><given-names> W.</given-names></name>,<name name-style="western"><surname> WANG</surname><given-names> D.</given-names></name>,<name name-style="western"><surname> PAPP</surname><given-names> A.C.</given-names></name>,<name name-style="western"><surname> PINSONNEAULT</surname><given-names> J.K.</given-names></name>,<name name-style="western"><surname> SMITH</surname><given-names> R.M.</given-names></name>,<name name-style="western"><surname> MOYER</surname><given-names> R.A. </given-names></name>,<name name-style="western"><surname> JOHNSON</surname><given-names> A.D. </given-names></name>,<etal>et al</etal>. (<year>2011</year>)<article-title>PHARMACOGENOMICS OF THE RNA WORLD: STRUCTURAL RNA POLYMORPHISMS IN DRUG THERAPY</article-title><source> CLINICAL PHARMACOLOGY &amp; THERAPEUTICS</source><volume> 89</volume>,<fpage> 355</fpage>-<lpage>365</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1038/CLPT.2010.314</pub-id></mixed-citation></ref><ref id="scirp.46550-ref42"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>GAUDREAULT</surname><given-names> I.</given-names></name>,<name name-style="western"><surname> GUAY</surname><given-names> D. </given-names></name>,<name name-style="western"><surname> LEBEL</surname><given-names> M. </given-names></name>,<etal>et al</etal>. (<year>2004</year>)<article-title>YB-1 PROMOTES STRAND SEPARATION IN VITRO OF DUPLEX DNA CONTAINING EITHER MISPAIRED BASES OR CISPLATIN MODIFICATIONS, EXHIBITS ENDONUCLEOLYTIC ACTIVITIES AND BINDS SEVERAL DNA REPAIR PROTEINS</article-title><source> NUCLEIC ACIDS RESEARCH</source><volume> 32</volume>,<fpage> 316</fpage>-<lpage>327</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1093/NAR/GKH170</pub-id></mixed-citation></ref><ref id="scirp.46550-ref43"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>JOEL</surname><given-names> P.</given-names></name>,<name name-style="western"><surname> SHAO</surname><given-names> W. </given-names></name>,<name name-style="western"><surname> PRATT</surname><given-names> K. </given-names></name>,<etal>et al</etal>. (<year>1993</year>)<article-title>A NUCLEAR PROTEIN WITH ENHANCED BINDING TO METHYLATED SP1 SITES IN THE AIDS VIRUS PROMOTER</article-title><source> NUCLEIC ACIDS RESEARCH</source><volume> 21</volume>,<fpage> 5786</fpage>-<lpage>5793</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1093/NAR/21.24.5786</pub-id></mixed-citation></ref><ref id="scirp.46550-ref44"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SHASTRY</surname><given-names> B.S. </given-names></name>,<etal>et al</etal>. (<year>2009</year>)<article-title>SNPS: IMPACT ON GENE FUNCTION AND PHENOTYPE</article-title><source> METHODS IN MOLECULAR BIOLOGY</source><volume> 578</volume>,<fpage> 3</fpage>-<lpage>22</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1007/978-1-60327-411-1_1</pub-id></mixed-citation></ref><ref id="scirp.46550-ref45"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>TENG</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> ICHIKAWA</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> PADGETT</surname><given-names> L.R.</given-names></name>,<name name-style="western"><surname> WANG</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> MORT</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> COOPER</surname><given-names> D.N.</given-names></name>,<name name-style="western"><surname> KOLLER</surname><given-names> D.L.</given-names></name>,<name name-style="western"><surname> FOROUD</surname><given-names> T.</given-names></name>,<name name-style="western"><surname> EDENBERG</surname><given-names> H.J.</given-names></name>,<name name-style="western"><surname> ECONS</surname><given-names> M.J. </given-names></name>,<name name-style="western"><surname> LIU</surname><given-names> Y. </given-names></name>,<etal>et al</etal>. (<year>2012</year>)<article-title>REGSNPS: A STRATEGY FOR PRIORITIZING REGULATORY SINGLE NUCLEOTIDE SUBSTITUTIONS</article-title><source> BIOINFORMATICS</source><volume> 28</volume>,<fpage> 1879</fpage>-<lpage>1886</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1093/BIOINFORMATICS/BTS275</pub-id></mixed-citation></ref></ref-list></back></article>